Annual ROE
-141.77%
-56.69%-66.63%
December 31, 2023
Summary
- As of February 22, 2025, RGLS annual return on equity is -141.77%, with the most recent change of -56.69% (-66.63%) on December 31, 2023.
- During the last 3 years, RGLS annual ROE has fallen by -73.44% (-107.48%).
- RGLS annual ROE is now -873.85% below its all-time high of 18.32%, reached on December 31, 2011.
Performance
RGLS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-53.07%
+2.40%+4.33%
September 30, 2024
Summary
- As of February 22, 2025, RGLS quarterly return on equity is -53.07%, with the most recent change of +2.40% (+4.33%) on September 30, 2024.
- Over the past year, RGLS quarterly ROE has increased by +2.40% (+4.33%).
- RGLS quarterly ROE is now -104.36% below its all-time high of 1216.00%, reached on September 30, 2019.
Performance
RGLS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
RGLS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -66.6% | +4.3% |
| 3 y3 years | -107.5% | +21.7% |
| 5 y5 years | +57.3% | -104.4% |
RGLS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -180.2% | at low | at high | +51.4% |
| 5 y | 5-year | -180.2% | +46.0% | at high | +92.8% |
| alltime | all time | -873.9% | +57.3% | -104.4% | +98.1% |
Regulus Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -53.07%(-4.3%) |
| Jun 2024 | - | -55.47%(-15.5%) |
| Mar 2024 | - | -65.68%(-39.8%) |
| Dec 2023 | -141.77%(+66.6%) | -109.19%(+15.9%) |
| Sep 2023 | - | -94.22%(+10.4%) |
| Jun 2023 | - | -85.35%(+5.4%) |
| Mar 2023 | - | -81.01%(+17.7%) |
| Dec 2022 | -85.08%(+68.1%) | -68.84%(+11.8%) |
| Sep 2022 | - | -61.56%(-9.1%) |
| Jun 2022 | - | -67.75%(+1.0%) |
| Mar 2022 | - | -67.08%(-10.8%) |
| Dec 2021 | -50.60%(-25.9%) | -75.20%(+1.7%) |
| Sep 2021 | - | -73.95%(+21.3%) |
| Jun 2021 | - | -60.96%(-33.0%) |
| Mar 2021 | - | -91.00%(-10.6%) |
| Dec 2020 | -68.33%(-74.0%) | -101.77%(-46.1%) |
| Sep 2020 | - | -188.81%(-21.7%) |
| Jun 2020 | - | -241.16%(-24.1%) |
| Mar 2020 | - | -317.94%(-56.6%) |
| Dec 2019 | -262.58%(-20.9%) | -732.43%(-160.2%) |
| Sep 2019 | - | 1216.00%(-143.3%) |
| Jun 2019 | - | -2806.04%(+258.6%) |
| Mar 2019 | - | -782.59%(+106.5%) |
| Dec 2018 | -331.78% | -379.06%(+64.8%) |
| Sep 2018 | - | -229.99%(+4.9%) |
| Jun 2018 | - | -219.35%(+6.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | -205.29%(+13.4%) |
| Dec 2017 | -157.53%(+73.4%) | -181.03%(+10.3%) |
| Sep 2017 | - | -164.10%(+11.6%) |
| Jun 2017 | - | -147.08%(+32.5%) |
| Mar 2017 | - | -111.04%(+21.7%) |
| Dec 2016 | -90.85%(+108.7%) | -91.23%(+37.0%) |
| Sep 2016 | - | -66.60%(+23.2%) |
| Jun 2016 | - | -54.06%(+10.2%) |
| Mar 2016 | - | -49.06%(+16.4%) |
| Dec 2015 | -43.54%(-13.4%) | -42.14%(-27.1%) |
| Sep 2015 | - | -57.81%(-2.8%) |
| Jun 2015 | - | -59.45%(+7.3%) |
| Mar 2015 | - | -55.40%(-7.4%) |
| Dec 2014 | -50.28%(+109.5%) | -59.80%(+43.2%) |
| Sep 2014 | - | -41.75%(+19.3%) |
| Jun 2014 | - | -34.99%(+11.5%) |
| Mar 2014 | - | -31.37%(+19.4%) |
| Dec 2013 | -24.00%(-85.8%) | -26.28%(-53.1%) |
| Sep 2013 | - | -56.08%(-51.0%) |
| Jun 2013 | - | -114.39%(-71.6%) |
| Mar 2013 | - | -402.65%(+3.5%) |
| Dec 2012 | -169.02%(-1022.6%) | -388.87%(-1031.4%) |
| Sep 2012 | - | 41.75%(+3.0%) |
| Jun 2012 | - | 40.53%(+216.9%) |
| Mar 2012 | - | 12.79%(+73.5%) |
| Dec 2011 | 18.32% | 7.37% |
FAQ
- What is Regulus Therapeutics annual return on equity?
- What is the all time high annual ROE for Regulus Therapeutics?
- What is Regulus Therapeutics annual ROE year-on-year change?
- What is Regulus Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Regulus Therapeutics?
- What is Regulus Therapeutics quarterly ROE year-on-year change?
What is Regulus Therapeutics annual return on equity?
The current annual ROE of RGLS is -141.77%
What is the all time high annual ROE for Regulus Therapeutics?
Regulus Therapeutics all-time high annual return on equity is 18.32%
What is Regulus Therapeutics annual ROE year-on-year change?
Over the past year, RGLS annual return on equity has changed by -56.69% (-66.63%)
What is Regulus Therapeutics quarterly return on equity?
The current quarterly ROE of RGLS is -53.07%
What is the all time high quarterly ROE for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly return on equity is 1216.00%
What is Regulus Therapeutics quarterly ROE year-on-year change?
Over the past year, RGLS quarterly return on equity has changed by +2.40% (+4.33%)